PRFX – painreform ltd. - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PRFX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/20

08:36 am

prfx

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial [Yahoo! Finance]

Medium Report

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial [Yahoo! Finance]

Report

11/20

08:30 am

prfx

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Low Report

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Report

11/7

05:07 pm

prfx

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement [Yahoo! Finance]

Low Report

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement [Yahoo! Finance]

Report

11/7

05:00 pm

prfx

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Low Report

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Report

10/25

09:26 am

prfx

PainReform cut to Hold at Maxim amid ‘changed' market dynamics [Yahoo! Finance]

Medium Report

PainReform cut to Hold at Maxim amid ‘changed' market dynamics [Yahoo! Finance]

Report

10/24

10:10 am

prfx

PainReform Ltd. (NASDAQ: PRFX) had its "hold" rating re-affirmed by analysts at Maxim Group.

Medium Report

PainReform Ltd. (NASDAQ: PRFX) had its "hold" rating re-affirmed by analysts at Maxim Group.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.